DIFLUNISAL is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by H. J. Harkins Company Inc.. The primary component is Diflunisal.
| Product ID | 52959-379_60e0ecab-9d00-3b1b-e053-2a91aa0af663 |
| NDC | 52959-379 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DIFLUNISAL |
| Generic Name | Diflunisal |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-12-22 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA073673 |
| Labeler Name | H. J. Harkins Company Inc. |
| Substance Name | DIFLUNISAL |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2017-12-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA073673 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-12-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA073673 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-12-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA073673 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-12-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA073673 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-12-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA073673 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-12-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA073673 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-12-22 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA073673 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-12-22 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| DIFLUNISAL | 500 mg/1 |
| SPL SET ID: | 60e0ecab-9cff-3b1b-e053-2a91aa0af663 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-0755 | Diflunisal | Diflunisal |
| 0093-9222 | Diflunisal | Diflunisal |
| 14539-673 | diflunisal | diflunisal |
| 23155-673 | diflunisal | diflunisal |
| 50090-0450 | DIFLUNISAL | DIFLUNISAL |
| 52959-379 | DIFLUNISAL | DIFLUNISAL |
| 55289-460 | Diflunisal | Diflunisal |
| 55700-559 | DIFLUNISAL | DIFLUNISAL |
| 60760-756 | Diflunisal | Diflunisal |
| 64980-181 | DIFLUNISAL | DIFLUNISAL |
| 68151-0848 | Diflunisal | Diflunisal |
| 68382-530 | Diflunisal | Diflunisal |
| 70771-1083 | Diflunisal | Diflunisal |